Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Nayuta Saito (Tokyo, Japan), Nayuta Saito, Yugo Kaneko, Yuri Baba, Hironori Kawamoto, Ikumi Fujisaki, Kai Ryu, Sho Watanabe, Tsugumi Horikiri, Aya Seki, Akira Kinoshita, Hiroshi Takeda, Keisuke Saito, Kazuyoshi Kuwano. The side effects, the outcome and the mortality of anti-tuberculosis treatment in dialyzed patients: A 10-year retrospective analysis. Eur Respir J 2015; 46: Suppl. 59, 2709

Member's Comments

No comment yet.

Related content which might interest you: The impact of adherence to guidelines for hospitalized community-acquired pneumonia on health outcomes and mortality: A retrospective cohort study Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015 Predictors of defaulting from treatment among patients with tuberculosis Source: International Congress 2015 – Management of TB: a patient focus Year: 2015 Effectiveness of mandatory treatment for tuberculosis - An observational registry study Source: Annual Congress 2013 –Epidemiological and public health features of tuberculosis Year: 2013 Treatment interruptions in patients with MDR/XDR-TB: risk factors and impact on treatment outcomes Source: International Congress 2016 – Drug-resistant tuberculosis and experiences with delamanid and bedaquiline Year: 2016 Could side effects of MDR-TB treatment change the outcome of the disease? Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015 Predictors of mortality in otherwise healthy patients with pulmonary tuberculosis: A retrospective cohort study Source: International Congress 2014 – Tuberculosis: epidemiology and public health Year: 2014 Impact of pre-treatment duration by first line drugs on treatment outcomes of patients with MDR-TB Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015 Empiric penicillin monotherapy of CAP is not associated with increased mortality; experiences from the retrospective CAP-North cohort Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016 Treatment outcome among HIV positive and HIV negative TB patients in Chandigarh, India: A retrospective cohort study Source: International Congress 2015 – Management of TB: a patient focus Year: 2015 Safety and risk factors for the morbidity and mortality of pneumonectomies: a retrospective 10-year study in a single institution Source: Virtual Congress 2020 – Thoracic surgery: malignancies Year: 2020 A retrospective analysis of outcome of Isoniazide preventive therapy in adults living with HIV in Penang, Malaysia Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA) Year: 2016 Outcome of failed empirical antibiotic therapy on the mortality of elderly patients with hospitalized pneumonia: A propensity score-based analysis Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections Year: 2013 The effects of antibiotic therapy at the pre-hospital stage on the in-hospital mortality in adults with community-acquired pneumonia in Russia: observational study results. Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice Year: 2020 Multinational, database cohort study to study mortality and risk factors of mortality in patients with asthma Source: International Congress 2016 – Asthma and allergy in infancy: from risk factors to mortality Year: 2016 Patients over 35 years experience more side-effects during latent TB treatment: Experience from an urban hospital with a high incidence of Tuberculosis Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015 Tuberculosis treatment outcome monitoring in European Union countries: systematic review Source: Eur Respir J 2013; 41: 635-643 Year: 2013 Latent tuberculosis infection prevalence and risk of developing active TB among patients eligible for starting anti-TNFα therapy Source: International Congress 2015 – Screening strategies in TB Year: 2015 Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study Source: Eur Respir J, 55 (5) 2000524; 10.1183/13993003.00524-2020 Year: 2020 Comorbidities and MDR-TB treatment outcomes in Georgia- 2009-11 cohort Source: International Congress 2014 – Tuberculosis: epidemiology and public health Year: 2014 Risk factors associated with MDR-TB deaths in Romania - 6 years retrospective study Source: International Congress 2018 – Drug-resistant tuberculosis Year: 2018